查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556195

2024 年人工胰臟裝置系統全球市場報告

Artificial Pancreas Device System Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

人工胰臟設備系統的市場規模預計在未來幾年將快速成長。 2028年，這一數字將以14%的複合年成長率成長至30.6億美元。預測期內的預期成長是由糖尿病患病率上升、胰腺癌發病率上升、糖尿病和肥胖率上升、對微創 (MI) 給藥系統的需求不斷成長以及糖尿病管理技術推動的。預測期內的主要趨勢包括技術創新、加強研發力度、增加產品核可、擴大夥伴關係和協作以及增加後續遠端諮詢活動。

胰臟癌盛行率的增加預計將推動人工胰臟裝置系統（APDS）市場的擴張。胰臟癌是一種發生在位於胃後方的胰臟的惡性。胰臟癌的發展受到生活方式、遺傳、醫療和環境因素的綜合影響，包括引起遺傳性胰臟炎並導致慢性胰臟炎的基因突變。人工胰臟裝置系統主要旨在透過自動監測血糖並輸送適量的胰島素來幫助糖尿病患者管理血糖值。例如，2024 年 3 月，澳洲政府機構 TheCancer Australia 估計，2023 年將有 4,506 例新診斷的胰臟癌病例，高於前五年的 3,751 例。因此，胰臟癌盛行率的上升促進了人工胰臟設備系統市場的成長。

人工胰臟設備系統市場的主要參與者正在開發自動化胰島素輸送系統，透過自動監測血糖值和施用適量的胰島素來改善糖尿病管理。這些系統旨在模仿健康胰臟的功能，減少持續血糖值監測和手動胰島素注射的需要。例如，2023 年 5 月，美國醫療設備製造商 Beta Bionics 的自動胰島素給藥設備 iLet 僅胰島素仿生胰臟系統獲得 FDA 510(k) 許可。這種人工胰臟系統自主地確定和管理胰島素劑量以調節血糖值。此封閉式系統根據連接的連續血糖監測儀（CGM）測量的血糖水平調整胰島素劑量，並且僅需要估計值用戶的體重和膳食量即可進行自動調整。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球人工胰臟設備系統市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球人工胰臟裝置系統市場表現：規模與成長，2018-2023
  • 全球人工胰臟裝置系統市場預測：規模與成長，2023-2028，2033F

第6章 市場細分

  • 全球人工胰臟裝置系統市場：按裝置類型分類的性能和預測，2018-2023、2023-2028F、2033F
  • 閾值暫停裝置系統
  • 控制距離系統
  • 控制目標系統
  • 全球人工胰臟裝置系統市場：依治療類型分類的表現與預測，2018-2023、2023-2028F、2033F
  • 雙激素
  • 僅胰島素
  • 混合
  • 全球人工胰臟裝置系統市場：最終用戶的表現與預測，2018-2023、2023-2028F、2033F
  • 醫院
  • 醫療中心
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球人工胰臟裝置系統市場：按地區分類的績效與預測，2018-2023、2023-2028F、2033F
  • 全球人工胰臟裝置系統市場：按國家分類的績效和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 人工胰臟裝置系統市場：競爭格局
  • 人工胰臟設備系統市場：公司簡介
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • DexCom Inc.
    • Insulet Corporation

第31章 其他大型創新企業

  • Tandem Diabetes Care Inc.
  • Juvenile Diabetes Research Foundation（JDRF）
  • Beta Bionics Inc.
  • Glooko Inc.
  • Bigfoot Biomedical Inc.
  • CeQur SA
  • Medtrum Technologies Inc.
  • Diabeloop SA
  • Beta-O2 Technologies Ltd
  • Pancreum Inc.
  • TypeZero Technologies LLC
  • Inreda Diabetic BV
  • Defymed SAS
  • Admetsys Corporation
  • DreaMed Diabetes Ltd

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r19543

An Artificial Pancreas Device System (APDS) is a medical technology designed to automate blood glucose management for people with diabetes. This system combines continuous glucose monitoring (CGM) with an insulin pump and employs a sophisticated algorithm to adjust insulin delivery automatically based on real-time glucose readings. The goal of the device is to replicate the glucose-regulating function of a healthy pancreas, thus minimizing the need for manual blood glucose monitoring and insulin injections, and assisting in keeping blood glucose levels within a target range.

The artificial pancreas device system market features three main types of devices threshold suspend device systems, control-to-range systems, and control-to-target systems. Threshold suspend device systems are insulin pump technologies that automatically halt insulin delivery when blood glucose levels fall below a set threshold. The different treatment types include bi-hormonal, insulin-only, and hybrid systems, with end-users such as hospitals, medical centers, and other healthcare settings.

The artificial pancreas device system market research report is one of a series of new reports from The Business Research Company that provides artificial pancreas device system market statistics, including the artificial pancreas device system industry global market size, regional shares, competitors with artificial pancreas device system market share, detailed artificial pancreas device system market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial pancreas device system industry. These artificial pancreas device system market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial pancreas device system market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.81 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The increase observed during the historic period can be attributed to several factors, including the rising influx of investments, expanding government initiatives in clinical research, increasing demand for automated glycemic control systems, intensive research and development efforts by industry players, and a growing geriatric population.

The artificial pancreas device system market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2028 at a compound annual growth rate (CAGR) of 14%. The anticipated growth during the forecast period can be attributed to the rising prevalence of diabetes, the increasing incidence of pancreatic cancer, the growing rates of diabetes and obesity, the higher demand for minimally invasive (MI) drug delivery systems, and advancements in diabetes management technology. Key trends in the forecast period include technological innovations, heightened research and development efforts, a rise in product approvals, growing partnerships and collaborations, and an increase in teleconsultancy activities for follow-up.

The growing incidence of pancreatic cancer is projected to drive the expansion of the artificial pancreas device system (APDS) market. Pancreatic cancer is a malignant tumor originating in the pancreas, which is located behind the stomach. The development of pancreatic cancer is influenced by a mix of lifestyle, genetic, medical, and environmental factors, including genetic mutations that can cause hereditary pancreatitis and result in chronic pancreatic inflammation. An artificial pancreas device system is primarily designed to assist individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For example, in March 2024, according to theCancer Australia, an Australia-based government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, up from 3,751 cases over the previous five years. Thus, the rising prevalence of pancreatic cancer is contributing to the growth of the artificial pancreas device system market.

Key players in the artificial pancreas device system market are developing automated insulin delivery systems to improve diabetes management by automatically monitoring blood glucose levels and administering the correct amount of insulin. These systems aim to mimic the function of a healthy pancreas, alleviating the need for constant blood sugar monitoring and manual insulin injections. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This artificial pancreas system autonomously determines and delivers insulin doses to regulate blood glucose levels. The closed-loop system adjusts insulin delivery based on glucose levels measured by a connected continuous glucose monitor (CGM), requiring only the user's body weight and a meal size estimate for automatic adjustments.

In September 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by integrating its leading Freestyle Libre continuous glucose monitoring technology with Bigfoot Biomedical's expertise in automated insulin delivery systems. Bigfoot Biomedical, a US-based company, specializes in developing prototypes of automated insulin delivery systems, also known as artificial pancreas systems.

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial pancreas device system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial pancreas device system market includes revenues earned by entities by providing services such as patient monitoring, device maintenance, data management, software updates, healthcare provider consultations, and training and support for patients and healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial pancreas device system market also includes sales of insulin pumps, continuous glucose monitors, control algorithms and software applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Pancreas Device System Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial pancreas device system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial pancreas device system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial pancreas device system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
  • 2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
  • 3) By End-User: Hospitals; Medical Centers; Other End-Users
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; DexCom Inc.; Insulet Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Pancreas Device System Market Characteristics

3. Artificial Pancreas Device System Market Trends And Strategies

4. Artificial Pancreas Device System Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Pancreas Device System Market Size and Growth

  • 5.1. Global Artificial Pancreas Device System Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Pancreas Device System Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Pancreas Device System Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Pancreas Device System Market Segmentation

  • 6.1. Global Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Threshold Suspend Device Systems
  • Control-To-Range Systems
  • Control-To-Target Systems
  • 6.2. Global Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bi-Hormonal
  • Insulin Only
  • Hybrid
  • 6.3. Global Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Medical Centers
  • Other End-Users

7. Artificial Pancreas Device System Market Regional And Country Analysis

  • 7.1. Global Artificial Pancreas Device System Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Pancreas Device System Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Pancreas Device System Market

  • 8.1. Asia-Pacific Artificial Pancreas Device System Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Pancreas Device System Market

  • 9.1. China Artificial Pancreas Device System Market Overview
  • 9.2. China Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Pancreas Device System Market

  • 10.1. India Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Pancreas Device System Market

  • 11.1. Japan Artificial Pancreas Device System Market Overview
  • 11.2. Japan Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Pancreas Device System Market

  • 12.1. Australia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Pancreas Device System Market

  • 13.1. Indonesia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Pancreas Device System Market

  • 14.1. South Korea Artificial Pancreas Device System Market Overview
  • 14.2. South Korea Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Pancreas Device System Market

  • 15.1. Western Europe Artificial Pancreas Device System Market Overview
  • 15.2. Western Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Pancreas Device System Market

  • 16.1. UK Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Pancreas Device System Market

  • 17.1. Germany Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Pancreas Device System Market

  • 18.1. France Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Pancreas Device System Market

  • 19.1. Italy Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Pancreas Device System Market

  • 20.1. Spain Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Pancreas Device System Market

  • 21.1. Eastern Europe Artificial Pancreas Device System Market Overview
  • 21.2. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Pancreas Device System Market

  • 22.1. Russia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Pancreas Device System Market

  • 23.1. North America Artificial Pancreas Device System Market Overview
  • 23.2. North America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Pancreas Device System Market

  • 24.1. USA Artificial Pancreas Device System Market Overview
  • 24.2. USA Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Pancreas Device System Market

  • 25.1. Canada Artificial Pancreas Device System Market Overview
  • 25.2. Canada Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Pancreas Device System Market

  • 26.1. South America Artificial Pancreas Device System Market Overview
  • 26.2. South America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Pancreas Device System Market

  • 27.1. Brazil Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Pancreas Device System Market

  • 28.1. Middle East Artificial Pancreas Device System Market Overview
  • 28.2. Middle East Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Pancreas Device System Market

  • 29.1. Africa Artificial Pancreas Device System Market Overview
  • 29.2. Africa Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Pancreas Device System Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Pancreas Device System Market Competitive Landscape
  • 30.2. Artificial Pancreas Device System Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. DexCom Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Insulet Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Pancreas Device System Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Juvenile Diabetes Research Foundation (JDRF)
  • 31.3. Beta Bionics Inc.
  • 31.4. Glooko Inc.
  • 31.5. Bigfoot Biomedical Inc.
  • 31.6. CeQur SA
  • 31.7. Medtrum Technologies Inc.
  • 31.8. Diabeloop SA
  • 31.9. Beta-O2 Technologies Ltd
  • 31.10. Pancreum Inc.
  • 31.11. TypeZero Technologies LLC
  • 31.12. Inreda Diabetic B.V.
  • 31.13. Defymed SAS
  • 31.14. Admetsys Corporation
  • 31.15. DreaMed Diabetes Ltd

32. Global Artificial Pancreas Device System Market Competitive Benchmarking

33. Global Artificial Pancreas Device System Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Pancreas Device System Market

35. Artificial Pancreas Device System Market Future Outlook and Potential Analysis

  • 35.1 Artificial Pancreas Device System Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Pancreas Device System Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Pancreas Device System Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer